2014 Executive Officer Compensation Arrangements
EX-10.4 3 jazzq12014ex104.htm JAZZ PHARMACEUTICALS PLC 2014 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS JAZZ Q1 2014 EX 10.4
Exhibit 10.4
2014 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate(2) |
Bruce C. Cozadd Chairman and Chief Executive Officer | $840,000 | 100 |
Russell J. Cox Executive Vice President and Chief Commercial Officer | $455,000 | 50 |
Suzanne Sawochka Hooper Executive Vice President and General Counsel | $485,000 | 50 |
Fintan Keegan Executive Vice President, Technical Operations | $376,667 | 50 |
Jeffrey K. Tobias, M.D. Executive Vice President, Research and Development and Chief Medical Officer | $430,000 | 50 |
Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer | $300,000 | 40 |
Matthew P. Young Senior Vice President and Chief Financial Officer | $415,000 | 40 |
(1) | 2014 Base salary rates generally effective by March 1, 2014. Mr. Keegan’s base salary is paid in Euro and is €275,000 for 2014. This conversion to U.S. dollars was calculated based on the average monthly exchange rate for December 2013 as reported by the OANDA Corporation. Mr. Young’s base salary rate is effective beginning on March 9, 2014, the effective date of his appointment as Chief Financial Officer. Prior to March 9, 2014, Mr. Young’s 2014 base salary rate was $360,500. |
(2) | Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans. |
